#32026D0739Commission Implementing Decision (EU) 2026/739 of 27 March 2026 revoking the authorisation for genetically modified maize MON 87419
AI-generated summary for informational purposes only. Not legal advice. See the original source for the authoritative text.
The European Commission has revoked the market authorisation for all products containing, consisting of or produced from genetically modified maize MON 87419. This decision repeals the previous authorisation granted by Implementing Decision (EU) 2023/2134. The revocation was requested by the authorisation holder, Bayer, who stated that the maize has never been cultivated in any country where cultivation is permitted and that the company has no intention of commercialising or introducing the product in the future. The decision is addressed to Bayer CropScience LLC in the United States, represented in the EU by Bayer Agriculture BV in Belgium.
AI-generated summary. May contain errors. Refer to official sources for legal decisions.
Key Changes
- Revocation of the authorisation for products containing, consisting of or produced from genetically modified maize MON 87419
- Repeal of Commission Implementing Decision (EU) 2023/2134 dated 13 October 2023
- Revocation requested by Bayer on 18 June 2025 due to no cultivation and no future commercialisation plans
+ 3 more changes with Pro
Obligations
What this law requires
Cease all market authorisation activities for products containing, consisting of or produced from genetically modified maize MON 87419, effective immediately upon this decision's entry into force
Remove all previously authorised products containing, consisting of or produced from genetically modified maize MON 87419 from EU market channels and distribution
Discontinue all labelling and marketing of genetically modified maize MON 87419 for food, feed, or non-food/non-feed uses (except cultivation, which remains prohibited)
Ensure Implementing Decision (EU) 2023/2134 is no longer referenced or applied as valid authorisation for MON 87419 products